0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immuno Oncology Assays Kit Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-34H832
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Immuno Oncology Assays Kit Market Insights Forecast to 2028
BUY CHAPTERS

Global Immuno Oncology Assays Kit Market Research Report 2025

Code: QYRE-Auto-34H832
Report
August 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Immuno Oncology Assays Kit Market Size

The global market for Immuno Oncology Assays Kit was valued at US$ 3797 million in the year 2024 and is projected to reach a revised size of US$ 5979 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Immuno Oncology Assays Kit Market

Immuno Oncology Assays Kit Market

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
The immuno-oncology assays kit market is driven by the growing demand for personalized and targeted cancer therapies and the increasing focus on immunotherapy research. Immuno-oncology assays kits are essential tools used in cancer research and clinical settings to assess the immune response to cancer and identify potential biomarkers for immunotherapy treatment. The rise in cancer incidence and the need for more effective and less toxic cancer treatments contribute to market growth. Moreover, advancements in immunoassay technology, such as multiplexing and high-throughput capabilities, have improved the accuracy and efficiency of immuno-oncology research. However, the market also faces challenges, including the complexity of the immune response in cancer, which requires a multifaceted approach for accurate assessment. Additionally, the variability of biomarkers among patients and the need for standardization and validation of assays can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer innovative and comprehensive immuno-oncology assays kits, collaborate with healthcare providers and researchers to address specific oncology research needs, and address the challenges to meet the increasing demand for effective tools for cancer immunotherapy research and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immuno Oncology Assays Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno Oncology Assays Kit.
The Immuno Oncology Assays Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immuno Oncology Assays Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno Oncology Assays Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Immuno Oncology Assays Kit Market Report

Report Metric Details
Report Name Immuno Oncology Assays Kit Market
Accounted market size in year US$ 3797 million
Forecasted market size in 2031 US$ 5979 million
CAGR 6.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina, PerkinElmer, Reaction Biology, Bio-Techne
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Immuno Oncology Assays Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Immuno Oncology Assays Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Immuno Oncology Assays Kit Market growing?

Ans: The Immuno Oncology Assays Kit Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Immuno Oncology Assays Kit Market size in 2031?

Ans: The Immuno Oncology Assays Kit Market size in 2031 will be US$ 5979 million.

Who are the main players in the Immuno Oncology Assays Kit Market report?

Ans: The main players in the Immuno Oncology Assays Kit Market are Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina, PerkinElmer, Reaction Biology, Bio-Techne

What are the Application segmentation covered in the Immuno Oncology Assays Kit Market report?

Ans: The Applications covered in the Immuno Oncology Assays Kit Market report are Research, Clinical Diagnostics

What are the Type segmentation covered in the Immuno Oncology Assays Kit Market report?

Ans: The Types covered in the Immuno Oncology Assays Kit Market report are Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing

Recommended Reports

Cancer Diagnostic Kits

Immunotherapy & CAR-T

Oncology Assay Kits

1 Immuno Oncology Assays Kit Market Overview
1.1 Product Definition
1.2 Immuno Oncology Assays Kit by Type
1.2.1 Global Immuno Oncology Assays Kit Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immunoassay
1.2.3 Flow Cytometry
1.2.4 PCR
1.2.5 Next Generation Sequencing
1.3 Immuno Oncology Assays Kit by Application
1.3.1 Global Immuno Oncology Assays Kit Market Value by Application (2024 VS 2031)
1.3.2 Research
1.3.3 Clinical Diagnostics
1.4 Global Immuno Oncology Assays Kit Market Size Estimates and Forecasts
1.4.1 Global Immuno Oncology Assays Kit Revenue 2020-2031
1.4.2 Global Immuno Oncology Assays Kit Sales 2020-2031
1.4.3 Global Immuno Oncology Assays Kit Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Immuno Oncology Assays Kit Market Competition by Manufacturers
2.1 Global Immuno Oncology Assays Kit Sales Market Share by Manufacturers (2020-2025)
2.2 Global Immuno Oncology Assays Kit Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Immuno Oncology Assays Kit Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Immuno Oncology Assays Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immuno Oncology Assays Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immuno Oncology Assays Kit, Product Type & Application
2.7 Global Key Manufacturers of Immuno Oncology Assays Kit, Date of Enter into This Industry
2.8 Global Immuno Oncology Assays Kit Market Competitive Situation and Trends
2.8.1 Global Immuno Oncology Assays Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Immuno Oncology Assays Kit Players Market Share by Revenue
2.8.3 Global Immuno Oncology Assays Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immuno Oncology Assays Kit Market Scenario by Region
3.1 Global Immuno Oncology Assays Kit Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Immuno Oncology Assays Kit Sales by Region: 2020-2031
3.2.1 Global Immuno Oncology Assays Kit Sales by Region: 2020-2025
3.2.2 Global Immuno Oncology Assays Kit Sales by Region: 2026-2031
3.3 Global Immuno Oncology Assays Kit Revenue by Region: 2020-2031
3.3.1 Global Immuno Oncology Assays Kit Revenue by Region: 2020-2025
3.3.2 Global Immuno Oncology Assays Kit Revenue by Region: 2026-2031
3.4 North America Immuno Oncology Assays Kit Market Facts & Figures by Country
3.4.1 North America Immuno Oncology Assays Kit Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Immuno Oncology Assays Kit Sales by Country (2020-2031)
3.4.3 North America Immuno Oncology Assays Kit Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immuno Oncology Assays Kit Market Facts & Figures by Country
3.5.1 Europe Immuno Oncology Assays Kit Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Immuno Oncology Assays Kit Sales by Country (2020-2031)
3.5.3 Europe Immuno Oncology Assays Kit Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immuno Oncology Assays Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Immuno Oncology Assays Kit Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Immuno Oncology Assays Kit Sales by Region (2020-2031)
3.6.3 Asia Pacific Immuno Oncology Assays Kit Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Immuno Oncology Assays Kit Market Facts & Figures by Country
3.7.1 Latin America Immuno Oncology Assays Kit Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Immuno Oncology Assays Kit Sales by Country (2020-2031)
3.7.3 Latin America Immuno Oncology Assays Kit Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immuno Oncology Assays Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Immuno Oncology Assays Kit Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Immuno Oncology Assays Kit Sales by Country (2020-2031)
3.8.3 Middle East and Africa Immuno Oncology Assays Kit Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Immuno Oncology Assays Kit Sales by Type (2020-2031)
4.1.1 Global Immuno Oncology Assays Kit Sales by Type (2020-2025)
4.1.2 Global Immuno Oncology Assays Kit Sales by Type (2026-2031)
4.1.3 Global Immuno Oncology Assays Kit Sales Market Share by Type (2020-2031)
4.2 Global Immuno Oncology Assays Kit Revenue by Type (2020-2031)
4.2.1 Global Immuno Oncology Assays Kit Revenue by Type (2020-2025)
4.2.2 Global Immuno Oncology Assays Kit Revenue by Type (2026-2031)
4.2.3 Global Immuno Oncology Assays Kit Revenue Market Share by Type (2020-2031)
4.3 Global Immuno Oncology Assays Kit Price by Type (2020-2031)
5 Segment by Application
5.1 Global Immuno Oncology Assays Kit Sales by Application (2020-2031)
5.1.1 Global Immuno Oncology Assays Kit Sales by Application (2020-2025)
5.1.2 Global Immuno Oncology Assays Kit Sales by Application (2026-2031)
5.1.3 Global Immuno Oncology Assays Kit Sales Market Share by Application (2020-2031)
5.2 Global Immuno Oncology Assays Kit Revenue by Application (2020-2031)
5.2.1 Global Immuno Oncology Assays Kit Revenue by Application (2020-2025)
5.2.2 Global Immuno Oncology Assays Kit Revenue by Application (2026-2031)
5.2.3 Global Immuno Oncology Assays Kit Revenue Market Share by Application (2020-2031)
5.3 Global Immuno Oncology Assays Kit Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fischer Scientific
6.1.1 Thermo Fischer Scientific Company Information
6.1.2 Thermo Fischer Scientific Description and Business Overview
6.1.3 Thermo Fischer Scientific Immuno Oncology Assays Kit Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fischer Scientific Immuno Oncology Assays Kit Product Portfolio
6.1.5 Thermo Fischer Scientific Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Company Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Immuno Oncology Assays Kit Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Diagnostics Immuno Oncology Assays Kit Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 Agilent Technologies
6.3.1 Agilent Technologies Company Information
6.3.2 Agilent Technologies Description and Business Overview
6.3.3 Agilent Technologies Immuno Oncology Assays Kit Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Agilent Technologies Immuno Oncology Assays Kit Product Portfolio
6.3.5 Agilent Technologies Recent Developments/Updates
6.4 Illumina
6.4.1 Illumina Company Information
6.4.2 Illumina Description and Business Overview
6.4.3 Illumina Immuno Oncology Assays Kit Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Illumina Immuno Oncology Assays Kit Product Portfolio
6.4.5 Illumina Recent Developments/Updates
6.5 PerkinElmer
6.5.1 PerkinElmer Company Information
6.5.2 PerkinElmer Description and Business Overview
6.5.3 PerkinElmer Immuno Oncology Assays Kit Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PerkinElmer Immuno Oncology Assays Kit Product Portfolio
6.5.5 PerkinElmer Recent Developments/Updates
6.6 Reaction Biology
6.6.1 Reaction Biology Company Information
6.6.2 Reaction Biology Description and Business Overview
6.6.3 Reaction Biology Immuno Oncology Assays Kit Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Reaction Biology Immuno Oncology Assays Kit Product Portfolio
6.6.5 Reaction Biology Recent Developments/Updates
6.7 Bio-Techne
6.7.1 Bio-Techne Company Information
6.7.2 Bio-Techne Description and Business Overview
6.7.3 Bio-Techne Immuno Oncology Assays Kit Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Techne Immuno Oncology Assays Kit Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immuno Oncology Assays Kit Industry Chain Analysis
7.2 Immuno Oncology Assays Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immuno Oncology Assays Kit Production Mode & Process Analysis
7.4 Immuno Oncology Assays Kit Sales and Marketing
7.4.1 Immuno Oncology Assays Kit Sales Channels
7.4.2 Immuno Oncology Assays Kit Distributors
7.5 Immuno Oncology Assays Kit Customer Analysis
8 Immuno Oncology Assays Kit Market Dynamics
8.1 Immuno Oncology Assays Kit Industry Trends
8.2 Immuno Oncology Assays Kit Market Drivers
8.3 Immuno Oncology Assays Kit Market Challenges
8.4 Immuno Oncology Assays Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Immuno Oncology Assays Kit Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Immuno Oncology Assays Kit Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Immuno Oncology Assays Kit Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Immuno Oncology Assays Kit Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Immuno Oncology Assays Kit Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Immuno Oncology Assays Kit Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Immuno Oncology Assays Kit Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Immuno Oncology Assays Kit Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Immuno Oncology Assays Kit, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Immuno Oncology Assays Kit, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Immuno Oncology Assays Kit, Product Type & Application
 Table 12. Global Key Manufacturers of Immuno Oncology Assays Kit, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Immuno Oncology Assays Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays Kit as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Immuno Oncology Assays Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Immuno Oncology Assays Kit Sales by Region (2020-2025) & (K Units)
 Table 18. Global Immuno Oncology Assays Kit Sales Market Share by Region (2020-2025)
 Table 19. Global Immuno Oncology Assays Kit Sales by Region (2026-2031) & (K Units)
 Table 20. Global Immuno Oncology Assays Kit Sales Market Share by Region (2026-2031)
 Table 21. Global Immuno Oncology Assays Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Immuno Oncology Assays Kit Revenue Market Share by Region (2020-2025)
 Table 23. Global Immuno Oncology Assays Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Immuno Oncology Assays Kit Revenue Market Share by Region (2026-2031)
 Table 25. North America Immuno Oncology Assays Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Immuno Oncology Assays Kit Sales by Country (2020-2025) & (K Units)
 Table 27. North America Immuno Oncology Assays Kit Sales by Country (2026-2031) & (K Units)
 Table 28. North America Immuno Oncology Assays Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Immuno Oncology Assays Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Immuno Oncology Assays Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Immuno Oncology Assays Kit Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Immuno Oncology Assays Kit Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Immuno Oncology Assays Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Immuno Oncology Assays Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Immuno Oncology Assays Kit Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Immuno Oncology Assays Kit Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Immuno Oncology Assays Kit Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Immuno Oncology Assays Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Immuno Oncology Assays Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Immuno Oncology Assays Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Immuno Oncology Assays Kit Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Immuno Oncology Assays Kit Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Immuno Oncology Assays Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Immuno Oncology Assays Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Immuno Oncology Assays Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Immuno Oncology Assays Kit Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Immuno Oncology Assays Kit Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Immuno Oncology Assays Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Immuno Oncology Assays Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Immuno Oncology Assays Kit Sales (K Units) by Type (2020-2025)
 Table 51. Global Immuno Oncology Assays Kit Sales (K Units) by Type (2026-2031)
 Table 52. Global Immuno Oncology Assays Kit Sales Market Share by Type (2020-2025)
 Table 53. Global Immuno Oncology Assays Kit Sales Market Share by Type (2026-2031)
 Table 54. Global Immuno Oncology Assays Kit Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Immuno Oncology Assays Kit Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Immuno Oncology Assays Kit Revenue Market Share by Type (2020-2025)
 Table 57. Global Immuno Oncology Assays Kit Revenue Market Share by Type (2026-2031)
 Table 58. Global Immuno Oncology Assays Kit Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Immuno Oncology Assays Kit Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Immuno Oncology Assays Kit Sales (K Units) by Application (2020-2025)
 Table 61. Global Immuno Oncology Assays Kit Sales (K Units) by Application (2026-2031)
 Table 62. Global Immuno Oncology Assays Kit Sales Market Share by Application (2020-2025)
 Table 63. Global Immuno Oncology Assays Kit Sales Market Share by Application (2026-2031)
 Table 64. Global Immuno Oncology Assays Kit Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Immuno Oncology Assays Kit Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Immuno Oncology Assays Kit Revenue Market Share by Application (2020-2025)
 Table 67. Global Immuno Oncology Assays Kit Revenue Market Share by Application (2026-2031)
 Table 68. Global Immuno Oncology Assays Kit Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Immuno Oncology Assays Kit Price (USD/Unit) by Application (2026-2031)
 Table 70. Thermo Fischer Scientific Company Information
 Table 71. Thermo Fischer Scientific Description and Business Overview
 Table 72. Thermo Fischer Scientific Immuno Oncology Assays Kit Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Thermo Fischer Scientific Immuno Oncology Assays Kit Product
 Table 74. Thermo Fischer Scientific Recent Developments/Updates
 Table 75. Roche Diagnostics Company Information
 Table 76. Roche Diagnostics Description and Business Overview
 Table 77. Roche Diagnostics Immuno Oncology Assays Kit Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Roche Diagnostics Immuno Oncology Assays Kit Product
 Table 79. Roche Diagnostics Recent Developments/Updates
 Table 80. Agilent Technologies Company Information
 Table 81. Agilent Technologies Description and Business Overview
 Table 82. Agilent Technologies Immuno Oncology Assays Kit Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Agilent Technologies Immuno Oncology Assays Kit Product
 Table 84. Agilent Technologies Recent Developments/Updates
 Table 85. Illumina Company Information
 Table 86. Illumina Description and Business Overview
 Table 87. Illumina Immuno Oncology Assays Kit Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Illumina Immuno Oncology Assays Kit Product
 Table 89. Illumina Recent Developments/Updates
 Table 90. PerkinElmer Company Information
 Table 91. PerkinElmer Description and Business Overview
 Table 92. PerkinElmer Immuno Oncology Assays Kit Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. PerkinElmer Immuno Oncology Assays Kit Product
 Table 94. PerkinElmer Recent Developments/Updates
 Table 95. Reaction Biology Company Information
 Table 96. Reaction Biology Description and Business Overview
 Table 97. Reaction Biology Immuno Oncology Assays Kit Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Reaction Biology Immuno Oncology Assays Kit Product
 Table 99. Reaction Biology Recent Developments/Updates
 Table 100. Bio-Techne Company Information
 Table 101. Bio-Techne Description and Business Overview
 Table 102. Bio-Techne Immuno Oncology Assays Kit Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Bio-Techne Immuno Oncology Assays Kit Product
 Table 104. Bio-Techne Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Immuno Oncology Assays Kit Distributors List
 Table 108. Immuno Oncology Assays Kit Customers List
 Table 109. Immuno Oncology Assays Kit Market Trends
 Table 110. Immuno Oncology Assays Kit Market Drivers
 Table 111. Immuno Oncology Assays Kit Market Challenges
 Table 112. Immuno Oncology Assays Kit Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Immuno Oncology Assays Kit
 Figure 2. Global Immuno Oncology Assays Kit Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Immuno Oncology Assays Kit Market Share by Type: 2024 & 2031
 Figure 4. Immunoassay Product Picture
 Figure 5. Flow Cytometry Product Picture
 Figure 6. PCR Product Picture
 Figure 7. Next Generation Sequencing Product Picture
 Figure 8. Global Immuno Oncology Assays Kit Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Immuno Oncology Assays Kit Market Share by Application: 2024 & 2031
 Figure 10. Research
 Figure 11. Clinical Diagnostics
 Figure 12. Global Immuno Oncology Assays Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Immuno Oncology Assays Kit Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Immuno Oncology Assays Kit Sales (2020-2031) & (K Units)
 Figure 15. Global Immuno Oncology Assays Kit Average Price (USD/Unit) & (2020-2031)
 Figure 16. Immuno Oncology Assays Kit Report Years Considered
 Figure 17. Immuno Oncology Assays Kit Sales Share by Manufacturers in 2024
 Figure 18. Global Immuno Oncology Assays Kit Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Immuno Oncology Assays Kit Players: Market Share by Revenue in Immuno Oncology Assays Kit in 2024
 Figure 20. Immuno Oncology Assays Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Immuno Oncology Assays Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Immuno Oncology Assays Kit Sales Market Share by Country (2020-2031)
 Figure 23. North America Immuno Oncology Assays Kit Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Immuno Oncology Assays Kit Sales Market Share by Country (2020-2031)
 Figure 27. Europe Immuno Oncology Assays Kit Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Immuno Oncology Assays Kit Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Immuno Oncology Assays Kit Revenue Market Share by Region (2020-2031)
 Figure 35. China Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Immuno Oncology Assays Kit Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Immuno Oncology Assays Kit Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Immuno Oncology Assays Kit Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Immuno Oncology Assays Kit Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Immuno Oncology Assays Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Immuno Oncology Assays Kit by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Immuno Oncology Assays Kit by Type (2020-2031)
 Figure 57. Global Immuno Oncology Assays Kit Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Immuno Oncology Assays Kit by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Immuno Oncology Assays Kit by Application (2020-2031)
 Figure 60. Global Immuno Oncology Assays Kit Price (USD/Unit) by Application (2020-2031)
 Figure 61. Immuno Oncology Assays Kit Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart